Literature DB >> 18086838

Increases in SLT2 expression and chitin content are associated with incomplete killing of Candida glabrata by caspofungin.

Jason M Cota1, Jodi L Grabinski, Robert L Talbert, David S Burgess, P David Rogers, Thomas D Edlind, Nathan P Wiederhold.   

Abstract

Incomplete killing was observed for caspofungin against Candida glabrata, which was associated with increased SLT2 expression and elevated chitin content. In contrast, fungicidal activity and no chitin increase were observed in an isogenic Delta slt2 strain, suggesting a role for SLT2 and chitin production in the response of C. glabrata to caspofungin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18086838      PMCID: PMC2258485          DOI: 10.1128/AAC.01542-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling.

Authors:  Cristina Reinoso-Martín; Christoph Schüller; Manuela Schuetzer-Muehlbauer; Karl Kuchler
Journal:  Eukaryot Cell       Date:  2003-12

2.  Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae.

Authors:  Sarit Markovich; Aya Yekutiel; Itamar Shalit; Yona Shadkchan; Nir Osherov
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

3.  Chs1p and Chs3p, two proteins involved in chitin synthesis, populate a compartment of the Saccharomyces cerevisiae endocytic pathway.

Authors:  M Ziman; J S Chuang; R W Schekman
Journal:  Mol Biol Cell       Date:  1996-12       Impact factor: 4.138

4.  Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods.

Authors:  M E Klepser; E J Ernst; R E Lewis; M E Ernst; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 5.  The protein kinase C-mediated MAP kinase pathway involved in the maintenance of cellular integrity in Saccharomyces cerevisiae.

Authors:  J J Heinisch; A Lorberg; H P Schmitz; J J Jacoby
Journal:  Mol Microbiol       Date:  1999-05       Impact factor: 3.501

6.  Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations.

Authors:  David A Stevens; Marife Espiritu; Rachana Parmar
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

7.  Effects of cilofungin (LY121019) on carbohydrate and sterol composition of Candida albicans.

Authors:  M Pfaller; J Riley; T Koerner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

8.  Differential expression and function of two homologous subunits of yeast 1,3-beta-D-glucan synthase.

Authors:  P Mazur; N Morin; W Baginsky; M el-Sherbeini; J A Clemas; J B Nielsen; F Foor
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

9.  Temperature-induced expression of yeast FKS2 is under the dual control of protein kinase C and calcineurin.

Authors:  C Zhao; U S Jung; P Garrett-Engele; T Roe; M S Cyert; D E Levin
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

10.  The function of chitin synthases 2 and 3 in the Saccharomyces cerevisiae cell cycle.

Authors:  J A Shaw; P C Mol; B Bowers; S J Silverman; M H Valdivieso; A Durán; E Cabib
Journal:  J Cell Biol       Date:  1991-07       Impact factor: 10.539

View more
  37 in total

1.  The Rho1 GTPase-activating protein CgBem2 is required for survival of azole stress in Candida glabrata.

Authors:  Sapan Borah; Raju Shivarathri; Rupinder Kaur
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

2.  Cell wall chitosaccharides are essential components and exposed patterns of the phytopathogenic oomycete Aphanomyces euteiches.

Authors:  Ilham Badreddine; Claude Lafitte; Laurent Heux; Nicholas Skandalis; Zacharoula Spanou; Yves Martinez; Marie-Thérèse Esquerré-Tugayé; Vincent Bulone; Bernard Dumas; Arnaud Bottin
Journal:  Eukaryot Cell       Date:  2008-09-19

Review 3.  Mechanisms of Antifungal Drug Resistance.

Authors:  Leah E Cowen; Dominique Sanglard; Susan J Howard; P David Rogers; David S Perlin
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

4.  Surface stress induces a conserved cell wall stress response in the pathogenic fungus Candida albicans.

Authors:  Clemens J Heilmann; Alice G Sorgo; Sepehr Mohammadi; Grazyna J Sosinska; Chris G de Koster; Stanley Brul; Leo J de Koning; Frans M Klis
Journal:  Eukaryot Cell       Date:  2012-12-14

5.  Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo.

Authors:  Keunsook K Lee; Donna M Maccallum; Mette D Jacobsen; Louise A Walker; Frank C Odds; Neil A R Gow; Carol A Munro
Journal:  Antimicrob Agents Chemother       Date:  2011-10-10       Impact factor: 5.191

6.  Assessment of caspofungin susceptibility of Candida glabrata by the Etest®, CLSI, and EUCAST methods, and detection of FKS1 and FKS2 mutations.

Authors:  N Bourgeois; C Laurens; S Bertout; Y Balard; D Krasteva; P Rispail; L Lachaud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-13       Impact factor: 3.267

Review 7.  Echinocandin antifungal drugs in fungal infections: a comparison.

Authors:  Sharon C-A Chen; Monica A Slavin; Tania C Sorrell
Journal:  Drugs       Date:  2011-01-01       Impact factor: 9.546

Review 8.  Chitin synthesis and fungal pathogenesis.

Authors:  Megan D Lenardon; Carol A Munro; Neil A R Gow
Journal:  Curr Opin Microbiol       Date:  2010-06-08       Impact factor: 7.934

9.  Dynamics of Mixed- Candida Species Biofilms in Response to Antifungals.

Authors:  G Vipulanandan; M Herrera; N P Wiederhold; X Li; J Mintz; B L Wickes; D Kadosh
Journal:  J Dent Res       Date:  2017-08-29       Impact factor: 6.116

10.  Fungal echinocandin resistance.

Authors:  Louise A Walker; Neil A R Gow; Carol A Munro
Journal:  Fungal Genet Biol       Date:  2009-09-19       Impact factor: 3.495

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.